PHARMACYNON
-
| StockNo |
Product description |
| EB0280-424-18 |
PHARMACYNON
AMPOULE 250 MG/2 ML |
-
- COMPOSITION:
Ethamsylate 250 mg/2 ml injection solution
ACTION:
The drug is with pronounced antihemorrhagic and angioprotective
properties. It restores the decreased capillary resistance, improves
microcirculation, normalizes the prolonged bleeding time and the
disturbed adhesion of platelets, without affecting prothrombin
levels. The hemostatic effect of pharmacynon is manifested 15 min
after intravenous injection. The maximum effect occurs after 1-2 h
and lasts from 4 to 6 h. Pharmacynon induces no blood
hypercoagulation and does not facilitate the formation of thrombi.
It is characterized by a good resorption and is excreted unchanged
with the urine, bile and feces.
INDICATIONS:
Prophylaxis, pre- and postoperative therapy of bleeding. Capillary
hemorrhages, resulting from hemorrhagic diathesis and traumas.
As angioprotective agent in cases of lower resistance or higher
premeability of the capillary wall, caused by hypertension,
atherosclerosis, diabetes, acrocyanosis, varices, etc.
In ophthalmology - it is widely used during microsurgical operations
and for the treatment of hemorrhagic retinopathy and glaucoma.
CONTRAINDICATIONS:
Hypersensitivity to the drug and in patients with predisposition to
thrombosis. |
SIDE EFFECTS:
Nausea, headache and reddening skin are rarely observed, and
discontinuation of treatment is necessary only in isolated cases.
PRECAUTIONS:
The injection solution should be used immediately after the ampoule
is opened and should not be mixed with other drugs in one syringe.
DOSAGE AND ADMINISTRATION:
It is parenterally administered: intravenously and intramuscularly.
For prophylaxis of hemorrhages - 1-2 ampoules prior to the
operation. Whenever necessary, 2-4 ml (1 to 2 ampoules) are
additionally injected during the operation. In case of risk of
postoperative hemorrhages - 4-6 ml (2 to 4 ampoules) are
prophylactically injected within 24 h.
Therapeutically - 2-4 ml (1 to 2 ampoules) and later - 2 ml (1
ampoule) are injected every 4-6 h. The daily dose should not be
exceeded in patients with chronic renal insufficiency: 500 mg (2
ampoules) daily!
Pharmacynon can be injected subconjunctivally and retrobulbarly in a
dose of 1 ml (1/2 ampoule).
MEDICINAL FORM AND PACKAGE:
Packages with 10 and 100 ampoules of 250 mg/2 ml.
STORAGE:
In a place protected from light, at moderate (15-30° C)
temperature.
EXPIRY:
3 (three) years.
|
